Abstract
A key component of Mendel’s work is what we now refer to as pleiotropy - when variation in one gene gives rise to variation in multiple phenotypes.
This study focuses on aiding genetic discovery in depression by revisiting the depressed phenotype and developing a quantitative trait in a large mixed family and population study, using analyses built upon the theory which underpins Mendel’s pleiotropic observations - the relationship between phenotypic variation and genetic variation.
Measures of genetic covariation were used to evaluate and rank ten measures of mood, personality, and cognitive ability as endophenotypes for depression. The highest-ranking traits were subjected to principal component analysis, and the first principal component used to create multivariate measures of depression.
Four traits fulfilled most endophenotype criteria, however, only two traits (neuroticism and the general health questionnaire) consistently ranked highest across all measures of covariation. As such, three composite traits were derived incorporating two, three, or four traits.
Composite traits were compared to the binary classification of depression and to their constituent univariate traits in terms of their coheritability, their ability to identify risk loci in a genome-wide association analysis, and phenotypic variance explained by polygenic profile scores for depression.
Association analyses of binary depression, univariate traits, and composite traits yielded no genome-wide significant results. However, composite traits were more heritable and more highly correlated with depression than their constituent traits, suggesting that analysing candidate endophenotypes in combination captures more of the heritable component of depression and may in part be limited by sample size in the current study.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Generation Scotland received core funding from the Chief Scientist Office of the Scottish Government Health Directorate CZD/16/6 and the Scottish Funding Council HR03006. Genotyping of the Generation Scotland samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland and was funded by the UK Medical Research Council and the Wellcome Trust (Wellcome Trust Strategic Award STratifying Resilience and Depression Longitudinally (STRADL) (Reference 104036/Z/14/Z). YZ acknowledges support from China Scholarship Council. AMMcI acknowledges support from the Dr Mortimer and Theresa Sackler Foundation. This work has made use of the resources provided by the Edinburgh Compute and Data Facility (http://www.ecdf.ed.ac.uk/).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Analyses were conducted using data from the Generation Scotland: The Scottish Family Health Study cohort, and UK Biobank under UK Biobank data application number 4844. Generation Scotland received ethical approval from the NHS Tayside Committee on Medical Research Ethics (REC Reference Numbers: 05/S1401/89 and 10/S1402/20). UK Biobank received ethical approval from the Research Ethics Committee (REC Reference Number: 11/NW/0382).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available to qualified researchers on a cost-recovery basis via online application processes, accessible via www.gsaccess.org and www.ukbiobank.ac.uk/register-apply/
